Peptidergic Neural Cells are neurons that use peptides as neurotransmitters to transmit signals within the nervous system. Unlike classic neurotransmitters like acetylcholine or serotonin, which are small molecules, peptides are larger molecules composed of amino acids. Peptidergic neurons are involved in diverse physiological processes, including pain modulation, stress response, and regulation of appetite. These neural cells synthesize and release neuropeptides, which act as signaling molecules to modulate the activity of other neurons, glands, or organs. Examples of neuropeptides include substance P, enkephalins, and neuropeptide Y. Each neuropeptide can have specific effects on target cells, influencing processes such as pain perception, mood, and appetite regulation. Peptidergic neural cells are found throughout the central and peripheral nervous systems. In the brain, they play crucial roles in the regulation of emotions, behavior, and responses to stress. In the peripheral nervous system, peptidergic neurons are involved in the modulation of sensory information, gastrointestinal functions, and immune responses. Research on peptidergic neural cells is significant for understanding the complexities of neural signaling and its impact on various physiological functions. Dysregulation of peptidergic systems has been implicated in conditions such as chronic pain, mood disorders, and metabolic disorders. Technological advancements, including molecular imaging and genetic tools, enable scientists to study peptidergic neural cells with greater precision. Targeting these cells and their associated neuropeptides holds promise for developing therapeutic interventions for disorders related to neural signaling and neuromodulation. In summary, peptidergic neural cells form a diverse and important component of the nervous system, utilizing neuropeptides as neurotransmitters to regulate various physiological functions. Exploring the intricacies of peptidergic signaling contributes to our understanding of neural communication and opens avenues for potential therapeutic interventions in neural and endocrine disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy